Humana Inc banner

Humana Inc
F:HUM

Watchlist Manager
Humana Inc Logo
Humana Inc
F:HUM
Watchlist
Price: 328 EUR 3.14% Market Closed
Market Cap: €39.6B

Humana Inc
Investor Relations

Humana is a U.S. health insurance company that mainly sells Medicare Advantage plans and related medical coverage for older adults. It also offers prescription drug plans, dental and vision coverage, and some employer and military-related health benefits. In simple terms, Humana helps members pay for doctor visits, hospital care, medicines, and preventive care through insurance products and care programs. Its main customers are seniors eligible for Medicare, along with some employers, government programs, and people who buy supplemental coverage. Humana makes money by collecting premiums and government payments tied to the plans it manages, then paying doctors, hospitals, pharmacies, and other providers when members use care. It also earns fees from services such as pharmacy benefit management, care management, and home-based health services. What makes Humana different is that it sits between the insurance world and the care-delivery world. It does not just sell insurance cards; it also tries to steer members toward preventive care, chronic disease management, and lower-cost treatment settings. That mix makes Humana both a payer and a care coordinator, which is a common but important role in U.S. healthcare.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2026
Call Date
Jul 29, 2026
AI Summary
Q2 2026

On track: Management said Humana is tracking to expectations for 2026 and remains on course for its 2028 goals, including a sustainable pretax margin of at least 3%.

2027 bids: The company plans meaningful margin expansion in 2027, using benefit changes, plan exits, and ongoing cost improvements to get there.

Stars progress: Humana said its Stars operating improvements are ahead of historical trends, but it still would not predict the final October outcome because CMS thresholds are unknown.

Cost trends: 2026 medical and pharmacy cost trends are still expected to be in the 7% to 8% range, with some favorability in inpatient care.

Efficiency gains: Operating model changes, including centralization and outsourcing, are already producing hundreds of millions of dollars in value this year.

Capital moves: Humana announced a roughly $900 million Gentiva divestiture, $1.5 billion in contingent capital facilities, and a new Illinois Medicaid contract set to begin in January 2027.

Key Financials
2026 cost trend
7% to 8%
2Q consolidated operating cost ratio
down 120 basis points
Individual MA pretax margin
double this year
Plan exits
approximately 600,000 members
Gentiva divestiture value
approximately $900 million
Contingent capital facilities
$1.5 billion
Stars improvement rate
5% ahead
Measures outpacing history
11 of the 12 measures
2028 pretax margin target
at least 3%
2027 Illinois Medicaid contract go-live
January of '27
Earnings Call Recording
Other Earnings Calls

Management

Ms. Susan Marie Diamond
Chief Financial Officer
No Bio Available
Mr. Joseph C. Ventura
Chief Legal Officer
No Bio Available
Mr. George Renaudin II
President of Medicare & Medicaid
No Bio Available
Dr. Sanjay K. Shetty M.B.A., M.D.
President of CenterWell
No Bio Available
Mr. James A. Rechtin M.B.A.
President, CEO & Director
No Bio Available
Mr. John-Paul William Felter
Senior VP, Chief Accounting Officer, Principal Accounting Officer & Controller
No Bio Available
Mr. Eric Tagliere
Senior VP & CTO
No Bio Available
Mr. Samir M. Deshpande
Chief Information Officer
No Bio Available
Ms. Lisa M. Stoner
Vice President of Investor Relations
No Bio Available
Dr. Vishal Agrawal M.D.
Chief Strategy & Corporate Development Officer
No Bio Available

Contacts

Address
KENTUCKY
Louisville
500 W Main St
Contacts
+15025801000.0
www.humana.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett